APA (7th ed.) Citation

Kamarul Bahrin, M. H., Al-Zarrad, D., Alexander, J., Arebi, N., Misra, R., Kamperidis, N., & Hart, A. (2024). P79 A UK-based experience of IV ustekinumab reloading strategy in patients with refractory crohn’s disease given in a tertiary IBD centre. Gut, 73(Suppl 1), A96-A97. https://doi.org/10.1136/gutjnl-2024-BSG.161

Chicago Style (17th ed.) Citation

Kamarul Bahrin, Muhammad Hafiz, Dania Al-Zarrad, James Alexander, Naila Arebi, Ravi Misra, Nikolaos Kamperidis, and Ailsa Hart. "P79 A UK-based Experience of IV Ustekinumab Reloading Strategy in Patients with Refractory Crohn’s Disease Given in a Tertiary IBD Centre." Gut 73, no. Suppl 1 (2024): A96-A97. https://doi.org/10.1136/gutjnl-2024-BSG.161.

MLA (9th ed.) Citation

Kamarul Bahrin, Muhammad Hafiz, et al. "P79 A UK-based Experience of IV Ustekinumab Reloading Strategy in Patients with Refractory Crohn’s Disease Given in a Tertiary IBD Centre." Gut, vol. 73, no. Suppl 1, 2024, pp. A96-A97, https://doi.org/10.1136/gutjnl-2024-BSG.161.